Evaluation of Cognitive Function of Patients Treated With Sunitinib or Sorafenib.
Phase of Trial: Phase IV
Latest Information Update: 01 Jan 2014
At a glance
- Drugs Sorafenib (Primary) ; Sunitinib (Primary)
- Indications Gastrointestinal stromal tumours; Renal cell carcinoma
- Focus Adverse reactions
- 01 Nov 2011 Actual end date (April 2011) added as reported by ClinicalTrials.gov.
- 01 Nov 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 02 Dec 2010 New trial record